Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2017 (2017), Article ID 2861596, 5 pages
https://doi.org/10.1155/2017/2861596
Case Report

Plasmablastic Lymphoma with Coexistence of Chronic Lymphocytic Leukemia in an Immunocompetent Patient: A Case Report and Mini-Review

1Department of Hematology, University Hospital of Ioannina, Ioannina, Greece
2Department of Pathology, University Hospital of Ioannina, Ioannina, Greece

Correspondence should be addressed to Eleftheria Hatzimichael; rg.iou.cc@miztahe

Received 10 September 2017; Accepted 18 October 2017; Published 20 November 2017

Academic Editor: Sotirios G. Papageorgiou

Copyright © 2017 Eleftheria Hatzimichael et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. D. Hsi, R. B. Lorsbach, F. Fend, and A. Dogan, “Plasmablastic lymphoma and related disorders,” American Journal of Clinical Pathology, vol. 136, no. 2, pp. 183–194, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. H. J. Delecluse, I. Anagnostopoulos, F. Dallenbach et al., “Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection,” Blood, vol. 89, no. 4, pp. 1413–1420, 1997. View at Google Scholar
  3. S. H. Swerdlow, E. Campo, S. A. Pileri et al., “The 2016 revision of the World Health Organization classification of lymphoid neoplasms,” Blood, vol. 127, no. 20, pp. 2375–2390, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. S. H. Swerdlow, E. Campo, N. L. Harris et al., Who Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press, Lyon, France, 2008.
  5. J. J. Castillo, E. S. Winer, D. Stachurski et al., “Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma,” Leukemia and Lymphoma, vol. 51, no. 11, pp. 2047–2053, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Colomo, F. Loong, S. Rives et al., “Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities,” American Journal of Surgical Pathology, vol. 28, no. 6, pp. 736–747, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J. E. Kim, Y. A. Kim, W. Y. Kim et al., “Human immunodeficiency virus-negative plasmablastic lymphoma in Korea,” Leukemia and Lymphoma, vol. 50, no. 4, pp. 582–587, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Scheper, N. G. Nikitakis, R. Fernandes, C. D. Gocke, R. A. Ord, and J. J. Sauk, “Oral plasmablastic lymphoma in an HIV-negative patient: a case report and review of the literature,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol. 100, no. 2, pp. 198–206, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Teruya-Feldstein, E. Chiao, D. A. Filippa et al., “CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients,” Annals of Oncology, vol. 15, no. 11, pp. 1673–1679, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. M. Tsimberidou, S. Wen, P. McLaughlin et al., “Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma,” Journal of Clinical Oncology, vol. 27, no. 6, pp. 904–910, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Hisada, R. J. Biggar, M. H. Greene, J. F. Fraumeni Jr., and L. B. Travis, “Solid tumors after chronic lymphocytic leukemia,” Blood, vol. 98, no. 6, pp. 1979–1981, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. Tsimberidou and M. J. Keating, “Richter syndrome: biology, incidence, and therapeutic strategies,” Cancer, vol. 103, no. 2, pp. 216–228, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. N. Richter, “Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia,” American Journal of Pathology, vol. 4, no. 4, pp. 285–292.7, 1928. View at Google Scholar
  14. C. R. Kjeldsberg and J. Marty, “Prolymphocytic transformation of chronic lymphocytic leukemia,” Cancer, vol. 48, no. 11, pp. 2447–2457, 1981. View at Publisher · View at Google Scholar
  15. B. M. Holderness, S. Malhotra, N. B. Levy, and A. V. Danilov, “Brentuximab vedotin demonstrates activity in a patient with plasmablastic lymphoma arising from a background of chronic lymphocytic leukemia,” Journal of Clinical Oncology, vol. 31, no. 12, pp. e197–e199, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Ronchi, L. Marra, F. Frigeri, G. Botti, R. Franco, and A. De Chiara, “Richter syndrome with plasmablastic lymphoma at primary diagnosis: a case report with a review of the literature,” Applied Immunohistochemistry and Molecular Morphology, vol. 25, no. 6, pp. e40–e45, 2017. View at Publisher · View at Google Scholar · View at Scopus
  17. E. S. Jaffe and S. Pittaluga, “Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification,” Hematology, vol. 2011, no. 1, pp. 506–514, 2011. View at Publisher · View at Google Scholar
  18. T. Robak, H. Urbanska-Rys, B. Strzelecka et al., “Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter’s syndrome,” European Journal of Haematology, vol. 67, no. 5-6, pp. 322–327, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. J. J. Castillo and J. L. Reagan, “Plasmablastic lymphoma: a systematic review,” Scientific World Journal, vol. 11, pp. 687–696, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. H. W. Wang, W. Yang, J. Z. Sun, J. Y. Lu, M. Li, and L. Sun, “Plasmablastic lymphoma of the small intestine: case report and literature review,” World Journal of Gastroenterology, vol. 18, no. 45, pp. 6677–6681, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Bockorny, I. Codreanu, and C. A. Dasanu, “Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature,” British Journal of Haematology, vol. 156, no. 1, pp. 50–66, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Lee, M. E. Skelly, D. W. Kingma, and L. J. Medeiros, “B-cell chronic lymphocytic leukemia followed by high grade T-cell lymphoma. An unusual variant of Richter’s syndrome,” American Journal of Clinical Pathology, vol. 103, no. 3, pp. 348–352, 1995. View at Publisher · View at Google Scholar
  23. D. Rossi, V. Spina, C. Deambrogi et al., “The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation,” Blood, vol. 117, no. 12, pp. 3391–3401, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Martinez, A. Valera, N. S. Perez et al., “Plasmablastic transformation of low-grade B-cell lymphomas: report on 6 cases,” American Journal of Surgical Pathology, vol. 37, no. 2, pp. 272–281, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. W. C. Foo, Q. Huang, S. Sebastian, C. B. Hutchinson, J. Burchette, and E. Wang, “Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus,” Human Pathology, vol. 41, no. 12, pp. 1802–1808, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Ramalingam, A. Nayak-Kapoor, M. Reid-Nicholson, J. Jones-Crawford, and C. Ustun, “Plasmablastic lymphoma with small lymphocytic lymphoma: clinico-pathologic features, and review of the literature,” Leukemia and Lymphoma, vol. 49, no. 10, pp. 1999–2002, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. G. Evans, P. G. Rothberg, W. R. Burack et al., “Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells,” British Journal of Haematology, vol. 171, no. 2, pp. 205–209, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. K. L. Chan, P. Blombery, K. Jones et al., “Plasmablastic Richter transformation as a resistance mechanism for chronic lymphocytic leukaemia treated with BCR signalling inhibitors,” British Journal of Haematology, vol. 177, no. 2, pp. 324–328, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. J. J. Castillo, E. S. Winer, D. Stachurski et al., “Prognostic factors in chemotherapy-treated patients with HIV-associated plasmablastic lymphoma,” Oncologist, vol. 15, no. 3, pp. 293–299, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Taddesse-Heath, A. Meloni-Ehrig, J. Scheerle, J. C. Kelly, and E. S. Jaffe, “Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features,” Modern Pathology, vol. 23, no. 7, pp. 991–999, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Gabrea, M. L. Martelli, Y. Qi et al., “Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors,” Genes, Chromosomes and Cancer, vol. 47, no. 7, pp. 573–590, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Moreau, P. G. Richardson, M. Cavo et al., “Proteasome inhibitors in multiple myeloma: 10 years later,” Blood, vol. 120, no. 5, pp. 947–959, 2012. View at Publisher · View at Google Scholar · View at Scopus